Medical cannabis-related stigma: cancer survivors' perspectives

doi: 10.1007/s11764-022-01297-7.

Online ahead of print.

Manan M Nayak^1 2 3, Anna Revette⁴, Peter R Chai^5 6 7, Kristina Lansang⁸, Timothy Sannes^9 10, Stephanie Tung^9 10, Ilana M Braun^9 10

Affiliations

PMID: 36435953
DOI: 10.1007/s11764-022-01297-7

Abstract

Background: Although the vast majority of medical cannabis laws in the USA includes cancer as a qualifying condition and medical cannabis-related stigma influences decision-making regarding the botanical, few studies have explored the phenomenon in oncology. Early findings indicated oncologic cannabis-related stigma to be quite widespread.

Methods: Semi-structured interviews with 24 adults with cancer histories using medical cannabis were analyzed using the Health Stigma and Discrimination Framework.

Results: Sixteen out of 24 participants discussed medical cannabis-related stigma in some depth. The phenomena emerged as more pervasive in medical than personal/professional domains and was internalized as well as experienced directly. It led some participants, but not others, to practice partial or complete secrecy.

Discussion: Taken together, our findings suggest that, while medical cannabis-related stigma remains widespread and led some study participants to alter behavior, an early shift in ethos towards greater medical cannabis acceptance could be underway. If so, this transition may be occurring more rapidly in non-medical than in clinical settings.

Conclusion: Cancer survivors may experience heightened medical cannabis-related stigma in the clinic as compared to their personal/professional lives. Healthcare providers who depend on patient transparency when gathering medical histories and devising care plans may wish to neutralize perceptions of medical cannabis-related stigma.

Keywords: Cannabis, Communication, Delivery of healthcare, Medical marijuana, Patient care team, Social status, Social stigma

References

1. Link BG, Phelan JC. Conceptualizing stigma. Annu Rev Soc. 2001;27(1).
1. Hatzenbuehler et al. Stigma as a fundamental cause of population health inequalities. American Journal of Public Health. 2013;103(2).
1. Victorson D, McMahon M, Horowitz B, et al. Exploring cancer survivors’ attitudes, perceptions, and concerns about using medical cannabis for symptom and side effect management: a qualitative focus group study. Complement Ther Med. 2019;47:102204. – DOI – PubMed
1. Bottorff JL, Bissell LJ, Balneaves LG, et al. Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study. Harm Reduction J. 2013;10(1):1–10. – DOI
1. McTaggart-Cowan H, Bentley C, Raymakers A, et al. Understanding cancer survivors’ reasons to medicate with cannabis: a qualitative study based on the theory of planned behavior. Cancer Med. 2021;10(1):396–404. – DOI – PubMed